Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anemia
Anemia treatment for patients with kidney disease can differ by dialysis facility type
May 2nd, 2007
Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, according to a study in JAMA. Anemia, a common complication of chronic kidney disease and end-stage renal disease (ESRD), occurs when there are too few red blood cells or the red blood cells are deficient in hemoglobin. The drug epoetin can be administered to increase red blood cell count to an appropriate range, and this is measured by hematocrit levels (the percentage of blood that is comprised of red blood cells). "By 2005, 99 percent of in-center...
Source: Biotech Week (2007-05-02)
|
